For this purpose, we cultured CD34+ cells from CML patients in the presence of hematopoietic growth factors and StemRegenin (hereafter named SR1), a well-known AHR antagonist. The gene discussed is AHR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.